Quality Payment Program Measures Data |
Back to Merit-based Incentive Payment System |
Measure ID | NQF ID | National Quality Strategy Domain | Title | High Priority | Measure Type | Submission Methods | Speciality Measure Sets | |
---|---|---|---|---|---|---|---|---|
HCPR20 | Patient Safety | Clostridium Difficile – Risk Assessment and Plan of Care | Process | Registry | Details | |||
HCPR22 | Communication and Care Coordination | Critical Care Transfer of Care – Use of Verbal Checklist or Protocol | Process | Registry | Details | |||
HCPR3 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – Pneumonia | Outcome | Registry | Details | |||
HCPR4 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – CHF | Outcome | Registry | Details | |||
HCPR5 | Efficiency and Cost Reduction | Mean Length of Stay for Inpatients – COPD | Outcome | Registry | Details | |||
ASNC19 | Patient Safety | Imaging Protocols for SPECT and PET MPI studies - Use of stress only protocol | Outcome | Registry | Details | |||
ASNC23 | Efficiency and Cost Reduction | SPECT-MPI study clinical utilization of Attenuation Correction image acquisition | Process | Registry | Details | |||
ASNC28 | Patient Safety | SPECT-MPI effective dose less than or equal to 9 millisieverts as per ASNC guideline recommendations | Outcome | Registry | Details | |||
ASNC29 | Communication and Care Coordination | SPECT and PET MPI study documentation of stress perfusion defects | Process | Registry | Details | |||
IGR1 | Efficiency and Cost Reduction | Comprehensive TTE studies reporting a measured value of LVEF AND wall motion findings with LVEF < 50% | Efficiency | Registry | Details | |||
IGR10 | Efficiency and Cost Reduction | Transthoracic Echo (TTE) performance per ASE guidelines | Efficiency | Registry | Details | |||
IGR11 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI), Transthoracic Echocardiography (TTE), or Stress Echocardiography studies meeting appropriate use criteria | Efficiency | Registry | Details | |||
IGR12 | Effective Clinical Care | Appropriate diagnosis verification and severity grading for valve disease through transthoracic echocardiography (TTE) quantitative parameters. | Process | Registry | Details | |||
IGR13 | Effective Clinical Care | Appropriate Evaluation of Left Ventricular Structure and Systolic Function with Transthoracic Echocardiography (TTE) to Guide Heart Failure and Cardiomyopathy Management | Process | Registry | Details | |||
IGR2 | Effective Clinical Care | Parameters in stress echocardiography dobutamine testing for low flow, low gradient aortic stenosis | Process | Registry | Details | |||
IGR4 | Efficiency and Cost Reduction | Myocardial Perfusion Imaging (MPI) studies or Stress Echocardiography imaging studies not Equivocal | Efficiency | Registry | Details | |||
IGR5 | Effective Clinical Care | Myocardial Perfusion Imaging (MPI) studies, Transthoracic Echo (TTE), or Stress Echocardiography imaging studies reporting Left Ventricular Ejection Fraction | Process | Registry | Details | |||
IGR6 | Effective Clinical Care | SPECT-MPI or Stress Echocardiography imaging protocol selection for morbidly obese patients | Efficiency | Registry | Details | |||
IGR7 | Effective Clinical Care | SPECT-MPI or Stress Echocardiography imaging studies with adequate exercise testing performed | Process | Registry | Details | |||
IGR8 | Effective Clinical Care | SPECT-MPI or Stress Echocardiography study utilization of exercise as a stressor | Process | Registry | Details |